
AI in MedTech: We need to strike the right balance between innovation and regulation
Stricter regulation is inevitable, so how should Medtech companies react? By Cognizant’s Rohit Alimchandani
Back to Top
Stricter regulation is inevitable, so how should Medtech companies react? By Cognizant’s Rohit Alimchandani
Diane Bullman reveals the difference mentoring made to this year’s participants and looks ahead to the 2025 programme – which includes a new stream run
Clinicians need a culture of education and understanding to get the best out of AI and protect themselves and their patients from inappropriate information, writes
As a service, pharmacy dislikes change, preferring to apply ‘band-aids’ to traditional systems. But the advantages of digitising are now too great to ignore, writes
Digital Health’s Advisory Panel invited members of the Shuri Network to join the panel last year. For Vicki Kong and Elohor Uwadiogbu it was a
Matt O’Donovan, the chief executive of SPARK TSL, argues that trusts and health boards need
There is huge scope to extend the reach and impact of virtual wards and remote
In the first of a two-part series on virtual wards, Tara Donnelly examines evidence of
At last month’s giant HIMSS in Orlando, you could ‘smell the money’. But it might
Shared care records are increasingly valued and developed but the obstacles in the way of